Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel Testing Method Detects HIV and Hepatitis B/C from Single Drop of Blood

By LabMedica International staff writers
Posted on 14 Apr 2023

Every year, over one million people succumb to hepatitis B or hepatitis C, while 650,000 die from HIV-related causes and 1. More...

5 million contract HIV. The World Health Organization aims to eliminate all three viruses by 2030, requiring new testing methods to decrease case numbers. The most common test for hepatitis B, hepatitis C, and HIV involves drawing blood from a vein with a needle. However, this approach is not always suitable in prisons, drug rehabilitation centers, and homeless shelters or in countries where blood sample shipping and refrigerated storage pose challenges. Alternative methods, such as dried blood spot tests, can detect nucleic acid from the three viruses in a single blood spot.

At this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark, (April 15–18), researchers at Copenhagen University Hospital (Copenhagen, Denmark) presented data on a test capable of detecting HIV, hepatitis B, and hepatitis C using a single drop of blood. The test involves pricking the individual's finger, collecting a few blood spots on filter paper, and allowing them to dry. The Hologic Panther System, commonly found in public health laboratories, then employs transcription mediated amplification to analyze one blood spot for genetic material from the three viruses.

The researchers assessed the test by analyzing 20 samples containing known amounts of HIV, hepatitis B, and hepatitis C using the dried blood spot method (60 samples in total) and successfully detected the viruses in all samples. Plasma dilution determined the lower detection limit, revealing the capability to detect the viruses at levels significantly lower than those typically found in untreated patients.

“We've shown that using existing hospital equipment, it is possible to detect HIV, hepatitis B and hepatitis C from a single drop of blood,” said Stephen Nilsson-Møller at the Department of Clinical Microbiology, Copenhagen University Hospital. “The dried blood spot test is ideal for places where you don't want to use a needle for safety reasons or where it is less practical. It is also suitable for developing countries or places where you run the risk of a blood sample being ruined before it is transferred to a laboratory that can analyze it. Blood samples need to be analyzed within six hours when kept at room temperature, while dried blood spots can last for nine months without refrigeration.”

Related Links:
Copenhagen University Hospital


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.